Isomorphic Labs
Isomorphic Laboratories applies advanced AI to accelerate and improve drug discovery, enabling researchers to design molecules and predict their performance earlier in development. The company builds on AlphaFold and deep learning models to model biological systems, generate candidate therapeutics, and simulate compound behavior. It operates as an AI-first drug discovery platform focused on strategic research collaborations with pharmaceutical companies, biotech firms, and CROs. Core technologies include machine learning, deep learning, and AlphaFold-derived protein-structure modeling. Isomorphic targets the biopharma market to shorten discovery timelines and increase predictive accuracy for therapeutic development.
Isomorphic Labs
Isomorphic Laboratories applies advanced AI to accelerate and improve drug discovery, enabling researchers to design molecules and predict their performance earlier in development. The company builds on AlphaFold and deep learning models to model biological systems, generate candidate therapeutics, and simulate compound behavior. It operates as an AI-first drug discovery platform focused on strategic research collaborations with pharmaceutical companies, biotech firms, and CROs. Core technologies include machine learning, deep learning, and AlphaFold-derived protein-structure modeling. Isomorphic targets the biopharma market to shorten discovery timelines and increase predictive accuracy for therapeutic development.
